New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy - ViDoe

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

1.5K views

Precision NanoSystems is now part of Cytiva

1 year ago

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

45:23

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

by Precision NanoSystems is now part of Cytiva

RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.

9:39

RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.

by Precision NanoSystems is now part of Cytiva

eTheRNA’s mRNA Lipid Nanoparticles LNP Technology Developed for its Cancer Immunotherapy Programs

59:31

eTheRNA’s mRNA Lipid Nanoparticles LNP Technology Developed for its Cancer Immunotherapy Programs

Cationic lipids offer new possibilities in liposome and LNP engineering for RNA therapeutics

28:37

Cationic lipids offer new possibilities in liposome and LNP engineering for RNA therapeutics

by Precision NanoSystems is now part of Cytiva

Translating mRNA-Based Medicines from Concept to Clinic

21:00

Translating mRNA-Based Medicines from Concept to Clinic

by Precision NanoSystems is now part of Cytiva

$Process \& Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles$

1:00:07

Process \& Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles

by Precision NanoSystems is now part of Cytiva

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform

23:48

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform

by Precision NanoSystems is now part of Cytiva

Insights on Lipid Nanoparticle Delivery and Scalable Microfluidic Manufacturing

31:39

Insights on Lipid Nanoparticle Delivery and Scalable Microfluidic Manufacturing

by Precision NanoSystems is now part of Cytiva

Is RNA Medicine the Next Paradigm Shift? Precision NanoSystems and the CRS BNLF Local Chapter

47:11

Is RNA Medicine the Next Paradigm Shift? Precision NanoSystems and the CRS BNLF Local Chapter

by Precision NanoSystems is now part of Cytiva

Challenges for mRNA LNP Formulation Development and Manufacturing

1:39

Challenges for mRNA LNP Formulation Development and Manufacturing

by Catalent Pharma Solutions

Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 Vaccine

28:21

Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 Vaccine

by Precision NanoSystems is now part of Cytiva

$TMS 9\/12\/21 ''Manufacturing of nucleic acid lipid nanoparticles for vaccine development''$

1:01:25

TMS 9\/12\/21 ''Manufacturing of nucleic acid lipid nanoparticles for vaccine development''

by Thursday morning Science

Novel Ionizable Lipid Library for Enabling Non-Viral Delivery – Dr. Lloyd Jeffs

24:29

Novel Ionizable Lipid Library for Enabling Non-Viral Delivery – Dr. Lloyd Jeffs

by Precision NanoSystems is now part of Cytiva

Webinar: Lipid nanoparticle LNP synthesis and CAR-T application

20:03

Webinar: Lipid nanoparticle LNP synthesis and CAR-T application

Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicines

2:36

Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicines

by Precision NanoSystems is now part of Cytiva

Developing Scalable RNA-LNP Drug Products for Clinical Readiness

22:07

Developing Scalable RNA-LNP Drug Products for Clinical Readiness

by Precision NanoSystems is now part of Cytiva

The use of RNA vaccines to promote CAR-T stimulation in solid tumors

2:02

The use of RNA vaccines to promote CAR-T stimulation in solid tumors

Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe Immunotherapy

23:24

Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe Immunotherapy

by Precision NanoSystems is now part of Cytiva

West Webinar - Scale Up: Bringing Nanomedicine from the Lab to the Clinic

38:51

West Webinar - Scale Up: Bringing Nanomedicine from the Lab to the Clinic

by Precision NanoSystems is now part of Cytiva